Cell Therapy for Prophylactic Tolerance in Immunoglobulin E-mediated Allergy.

•Avoidance of IgE-mediated allergy is established by development of a tolerogenic cell-based protocol.•Transplantation of syngeneic allergen-bearing bone marrow cells into recipients leads to tolerance towards the introduced allergen.•Prevention of T-and B-cell responses and allergic asthma is induced by cell transfer with non-toxic pretreatment.